INDRAMEDCO
Invest with MTF
Invest Now
Invest in Indraprastha Medical Corporation with 2.08X leverage
Performance
- Low
- ₹389
- High
- ₹407
- 52 Week Low
- ₹307
- 52 Week High
- ₹641
- Open Price₹389
- Previous Close₹392
- Volume262,241
- 50 DMA₹423.94
- 100 DMA₹449.88
- 200 DMA₹451.96
Investment Returns
- Over 1 Month -2.63%
- Over 3 Month -35.18%
- Over 6 Month -10.77%
- Over 1 Year -13.86%
Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!
Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.1
- PEG Ratio
- 1
- Market Cap Cr
- 3,684
- P/B Ratio
- 5.6
- Average True Range
- 17.09
- EPS
- 19.95
- Dividend Yield
- 1.1
- MACD Signal
- -18.48
- RSI
- 51.37
- MFI
- 56.45
Indraprastha Medical Corporation Financials
Indraprastha Medical Corporation Technicals
EMA & SMA
Current Price
₹401.85
+
10.35
(2.64%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹391.06
- 50 Day
- ₹423.94
- 100 Day
- ₹449.88
- 200 Day
- ₹451.96
Resistance and Support
399.35
- R3 427.30
- R2 417.15
- R1 409.50
- S1 391.70
- S2 381.55
- S3 373.90
Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends
Indraprastha Medical Corporation F&O
About Indraprastha Medical Corporation
- NSE Symbol
- INDRAMEDCO
- BSE Symbol
- 532150
- Managing Director
- Mr. Shivakumar Pattabhiraman
- ISIN
- INE681B01017
Similar Stocks to Indraprastha Medical Corporation
Indraprastha Medical Corporation FAQs
Indraprastha Medical Corporation share price is ₹401 As on 10 February, 2026 | 22:01
The Market Cap of Indraprastha Medical Corporation is ₹3683.9 Cr As on 10 February, 2026 | 22:01
The P/E ratio of Indraprastha Medical Corporation is 20.1 As on 10 February, 2026 | 22:01
The PB ratio of Indraprastha Medical Corporation is 5.6 As on 10 February, 2026 | 22:01
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.